D
Patient 1
(B)(4). THE MANUFACTURER IDENTIFIED THAT THE CUSTOMER ORDER WAS PROCESSED AND SHIPPED WITH THE INCORRECT ACTIVITY OF IODINE SEEDS. THE CUSTOMER WAS CONTACTED PRIOR TO USE.
| Seq | Brand | Generic | Manufacturer | Product code | Model | Catalog | Lot | PMA | 510(k) | Implant | Evaluated | Availability |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BRACHYSOURCE I-125 IMPLANT, LOOSE, STERILE | BARD BRACHYTHERAPY, INC. | KXK | NA | PS-1251LS | UNK | R | N |
| Sequence | Received | Treatment | Outcome |
|---|---|---|---|
| 1 | 2013-06-20 | 0 |
Patient 1
(B)(4). THE MANUFACTURER IDENTIFIED THAT THE CUSTOMER ORDER WAS PROCESSED AND SHIPPED WITH THE INCORRECT ACTIVITY OF IODINE SEEDS. THE CUSTOMER WAS CONTACTED PRIOR TO USE.
Patient 1
THE INVESTIGATION REMAINS IN PROCESS. A SUPPLEMENTAL REPORT WILL BE SENT UPON COMPLETION OF THE INVESTIGATION.